Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat for Renal Anemia in Heart Failure
jRCT1041210164Recruiting
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vadadustat in heart failure (HF), anemia of renal disease and chronic kidney disease (CKD) (2 arms). Primary endpoint: Change in NT-proBNP at 24 weeks. Started Mar 2022; status: recruiting.
02
Drugs
vadadustat
03
Conditions
heart failure (HF)anemia of renal diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT1041210164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041210164.